المؤلفون: Bosso D., Pagliuca M., Sonpavde G., Pond G., Lucarelli G., Rossetti S., Facchini G., Scagliarini S., Carteni G., Daniele B., Morelli F., Ferro M., Puglia L., Izzo M., Montanaro V., Bellelli T., Vitrone F., De Placido S., Buonerba C., Di Lorenzo G.

المساهمون: Bosso, D., Pagliuca, M., Sonpavde, G., Pond, G., Lucarelli, G., Rossetti, S., Facchini, G., Scagliarini, S., Carteni, G., Daniele, B., Morelli, F., Ferro, M., Puglia, L., Izzo, M., Montanaro, V., Bellelli, T., Vitrone, F., De Placido, S., Buonerba, C., Di Lorenzo, G.

مصطلحات موضوعية: castration-resistant setting, enzalutamide, prostate cancer, PSA, Aged, Antineoplastic Agents, Hormonal, Biomarkers, Tumor, Human, Male, Multivariate Analysi, Phenylthiohydantoin, Prognosi, Proportional Hazards Model, Prostate-Specific Antigen, Prostatic Neoplasms, Castration-Resistant, Retrospective Studie, Severity of Illness Index, Survival Analysis

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000403594100003; volume:96; issue:24; firstpage:e6817; journal:MEDICINE; http://hdl.handle.net/11588/789597Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85021959657; http://journals.lww.com/md-journalTest

الإتاحة: https://doi.org/10.1097/MD.0000000000006817Test
http://hdl.handle.net/11588/789597Test
http://journals.lww.com/md-journalTest

المؤلفون: Buonerba C., Sonpavde G., Vitrone F., Bosso D., Puglia L., Izzo M., Iaccarino S., Scafuri L., Muratore M., Foschini F., Mucci B., Tortora V., Pagliuca M., Ribera D., Riccio V., Morra R., Mosca M., Cesarano N., Di Costanzo I., De Placido S., Di Lorenzo G.

المساهمون: Buonerba, C., Sonpavde, G., Vitrone, F., Bosso, D., Puglia, L., Izzo, M., Iaccarino, S., Scafuri, L., Muratore, M., Foschini, F., Mucci, B., Tortora, V., Pagliuca, M., Ribera, D., Riccio, V., Morra, R., Mosca, M., Cesarano, N., Di Costanzo, I., De Placido, S., Di Lorenzo, G.

مصطلحات موضوعية: Cabazitaxel, Prostate cancer, PSA decline

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000410580800001; volume:8; issue:14; firstpage:2663-2668; lastpage:2668; journal:JOURNAL OF CANCER; http://hdl.handle.net/11588/789593Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028500540; http://www.jcancer.org/v08p2663.pdfTest

الإتاحة: https://doi.org/10.7150/jca.20040Test
http://hdl.handle.net/11588/789593Test
http://www.jcancer.org/v08p2663.pdfTest

المؤلفون: Tombolini, V., Staso, M. Di, Bonfili, P., Pagliuca, M. Di Genesio, Franzese, P., Buonopane, S., Valeriani, M., Enrici, R. Maurizi, Festuccia, C., Gravina, G. L.

المصدر: Prostate Cancer & Prostatic Diseases; 2010, Vol. 13 Issue 1, p34-38, 5p, 5 Charts

مصطلحات موضوعية: PROSTATE cancer, CANCER treatment, CANCER in men, RADIOTHERAPY, QUALITY of life

المؤلفون: Brigitta Mucci, Livio Puglia, Sabino De Placido, Guru Sonpavde, Francesca Foschini, Carlo Buonerba, Simona Iaccarino, Ileana Di Costanzo, Giuseppe Di Lorenzo, Francesca Vitrone, Vincenzo Tortora, Vittorio Riccio, Luca Scafuri, Margherita Muratore, Dario Ribera, Davide Bosso, Mirta Mosca, Martina Pagliuca, Nicola Cesarano, Michela Izzo, Rocco Morra

المساهمون: Buonerba, C., Sonpavde, G., Vitrone, F., Bosso, D., Puglia, L., Izzo, M., Iaccarino, S., Scafuri, L., Muratore, M., Foschini, F., Mucci, B., Tortora, V., Pagliuca, M., Ribera, D., Riccio, V., Morra, R., Mosca, M., Cesarano, N., Di Costanzo, I., De Placido, S., Di Lorenzo, G.

المصدر: Journal of Cancer

مصطلحات موضوعية: Oncology, medicine.medical_specialty, PSA decline, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Prednisone, Internal medicine, medicine, 030212 general & internal medicine, Taxane, Cabazitaxel, business.industry, medicine.disease, Docetaxel, 030220 oncology & carcinogenesis, Concomitant, Cohort, Prednisolone, business, Research Paper, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1bf287bdf1551393db0df7f27ce1addTest
http://hdl.handle.net/11588/789593Test

المؤلفون: Giacomo Cartenì, Sabino De Placido, Guru Sonpavde, Franco Morelli, Sabrina Rossetti, Gregory R. Pond, Giuseppe Di Lorenzo, Gaetano Facchini, Bruno Daniele, Vittorino Montanaro, Giuseppe Lucarelli, Matteo Ferro, Michela Izzo, Sarah Scagliarini, Teresa Bellelli, Carlo Buonerba, Francesca Vitrone, Livio Puglia, Davide Bosso, Martina Pagliuca

المساهمون: Bosso, D., Pagliuca, M., Sonpavde, G., Pond, G., Lucarelli, G., Rossetti, S., Facchini, G., Scagliarini, S., Carteni, G., Daniele, B., Morelli, F., Ferro, M., Puglia, L., Izzo, M., Montanaro, V., Bellelli, T., Vitrone, F., De Placido, S., Buonerba, C., Di Lorenzo, G.

المصدر: Medicine. 96:e6817

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, castration-resistant setting, Antineoplastic Agents, Hormonal, Prognosi, Severity of Illness Index, PSA, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Retrospective Studie, Internal medicine, Phenylthiohydantoin, Severity of illness, Biomarkers, Tumor, medicine, Enzalutamide, 030212 general & internal medicine, Multivariate Analysi, Survival analysis, Aged, enzalutamide, Proportional hazards model, business.industry, Medical record, Retrospective cohort study, General Medicine, Prostate-Specific Antigen, prostate cancer, medicine.disease, Survival Analysis, Prostatic Neoplasms, Castration-Resistant, Prostate-specific antigen, chemistry, 030220 oncology & carcinogenesis, Proportional Hazards Model, business, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd7b35c5d61f0f694f37e460ea22750eTest
https://doi.org/10.1097/md.0000000000006817Test